Richard J. Napolitano - 01 Mar 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF ACCOUNTING OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
01 Mar 2024
Net transactions value
-$54,653
Form type
4
Filing time
05 Mar 2024, 16:11:16 UTC
Previous filing
02 Feb 2024
Next filing
20 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1,604 +14% 13,353 01 Mar 2024 Direct F1
transaction TDOC Common Stock Options Exercise +504 +3.8% 13,857 01 Mar 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1,481 +11% 15,338 01 Mar 2024 Direct F2
transaction TDOC Common Stock Options Exercise +337 +2.2% 15,675 01 Mar 2024 Direct F2
transaction TDOC Common Stock Options Exercise +565 +3.6% 16,240 01 Mar 2024 Direct F2
transaction TDOC Common Stock Options Exercise +894 +5.5% 17,134 01 Mar 2024 Direct F2
transaction TDOC Common Stock Options Exercise +4,708 +27% 21,842 01 Mar 2024 Direct F2
transaction TDOC Common Stock Sale $54,653 -3,765 -17% $14.52 18,077 04 Mar 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Award $0 +4,814 $0.000000 4,814 01 Mar 2024 Common Stock 4,814 Direct F4, F5, F6
transaction TDOC Performance Stock Units Options Exercise $0 -1,604 -33% $0.000000 3,210 01 Mar 2024 Common Stock 1,604 Direct F1, F7
transaction TDOC Performance Stock Units Award $0 +1,515 $0.000000 1,515 01 Mar 2024 Common Stock 1,515 Direct F4, F5, F6
transaction TDOC Performance Stock Units Options Exercise $0 -504 -33% $0.000000 1,011 01 Mar 2024 Common Stock 504 Direct F1, F8
transaction TDOC Restricted Stock Units Options Exercise $0 -1,481 -33% $0.000000 2,963 01 Mar 2024 Common Stock 1,481 Direct F2, F9
transaction TDOC Restricted Stock Units Options Exercise $0 -337 -20% $0.000000 1,348 01 Mar 2024 Common Stock 337 Direct F2, F10
transaction TDOC Restricted Stock Units Options Exercise $0 -565 -20% $0.000000 2,260 01 Mar 2024 Common Stock 565 Direct F2, F11
transaction TDOC Restricted Stock Units Options Exercise $0 -894 -17% $0.000000 4,472 01 Mar 2024 Common Stock 894 Direct F2, F12
transaction TDOC Restricted Stock Units Options Exercise $0 -4,708 -33% $0.000000 9,418 01 Mar 2024 Common Stock 4,708 Direct F2, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
F5 Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
F6 The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7 On March 1, 2024, the reporting person earned 4,614 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8 On March 1, 2024, the reporting person earned 1,515 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F9 On May 1, 2023, the reporting person was granted 4,444 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F10 On March 1, 2022, the reporting person was granted 4,043 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F11 On April 1, 2022, the reporting person was granted 6,778 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F12 On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F13 On March 3, 2023, the reporting person was granted 14,126 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.